AHA files motions as 340B case returns to district court to determine remedy
Following its unanimous victory in the U.S. Supreme Court earlier this summer, AHA yesterday asked the U.S. District Court for the District of Columbia to order the Department of Health and Human Services to immediately stop underpaying certain hospitals that participate in the 340B Drug Pricing Program and promptly repay them for the unlawful cuts since 2018 without penalizing other hospitals.
Related News Articles
Headline
Deceptively branded as an effort to save the 340B program, a legislative campaign by the Pharmaceutical Research and Manufacturers of America, National…
Headline
Following the recent district court decision to remand to the Department of Health and Human Services the question of how to repay 340B hospitals for…
Headline
Drugmakers that participate in the 340B drug pricing program do not have to provide discounted 340B drugs to an unlimited number of contract pharmacies, the U.…
Headline
As drug prices continue to rise, the 340B drug pricing program continues to help hospitals expand access to comprehensive health services, including lifesaving…
Headline
The U.S. District Court for the District of Columbia today decided to allow the Department of Health and Human Services to propose an appropriate remedy for…
Perspective
The convening of the 118th Congress this week is a reminder of Washington’s highly-charged political environment.
The once-in-a-century floor tussle over the…